COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD

被引：0
|
作者：
Aoyama, Junichi [1 ]
Tanaka, Yosuke [1 ]
Kosaihira, Seiji [1 ]
Okano, Tetuya [1 ]
Hino, Mitunori [1 ]
Seike, Masahiro [1 ]
Gemma, Akihiko [1 ]
机构：
[1] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Resp Med, Chiba, Japan
来源：
RESPIROLOGY | 2019年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP1424
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [1] EVELUT®: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, R.
    Dreher, M.
    Mattiucci-Guehlke, M.
    Eckhardt, S.
    Taube, C.
    Vogelmeier, C.
    Buhl, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] LAMA/LABA oder LABA/ICS?
    Michael Hubert
    [J]. MMW - Fortschritte der Medizin, 2015, 157 (14) : 76 - 76
  • [3] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
    Hizawa, Nobuyuki
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1093 - 1102
  • [4] Step up to ICS/LAMA/LABA vs switch to LAMA/LABA in patients with COPD on ICS/LABA: post hoc analysis of KRONOS
    Singh, Dave
    Bafadhel, Mona
    Bowen, Karin
    Arya, Niki
    Marshall, Jonathan
    Parikh, Himanshu
    Patel, Mehul
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] ICS/LABA/LAMA wirksamer als LABA/LAMA
    Fath R.
    [J]. MMW - Fortschritte der Medizin, 2018, 160 (18) : 69 - 69
  • [6] A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD
    Matera, Maria Gabriella
    Calzetta, Luigino
    Puxeddu, Ermanno
    Rogliani, Paola
    Cazzola, Mario
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (05) : 509 - 517
  • [7] The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
    De Backer, Wilfried
    Vos, Wim
    Van Holsbeke, Cedric
    Vinchurkar, Samir
    Claes, Rita
    Hufkens, Annemie
    Parizel, Paul M.
    Bedert, Lieven
    De Backer, Jan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (02) : 527 - 529
  • [8] EFFECTIVENESS OF COPD MAINTENANCE THERAPY WITH LAMA/LABA VS LAMA/LABA/ICS IN A UNITED STATES CLAIMS DATABASE
    Quint, Jennifer
    Montonen, Jukka
    He, Xintong
    de la Hoz, Alberto
    Esposito, Daina
    [J]. CHEST, 2021, 160 (04) : 1863A - 1864A
  • [9] LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
    Rodrigo, Gustavo J.
    Price, David
    Anzueto, Antonio
    Singh, Dave
    Altman, Pablo
    Bader, Giovanni
    Patalano, Francesco
    Fogel, Robert
    Kostikas, Konstantinos
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 907 - 922
  • [10] Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
    Singh, Dave
    Fabbri, Leonardo M.
    Vezzoli, Stefano
    Petruzzelli, Stefano
    Papi, Alberto
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 531 - 546
12345